Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Xeloda recommended for E.U. approval for advanced gastric cancer

Feb. 26, 2007

Novel synthetic diazonamide A analogue shows promise in preclinical studies

Feb. 26, 2007

Peregrine licensee begins phase I trial with TNT cancer agent

Feb. 26, 2007

New phase I trial studies L-annamycin in pediatric ALL and AML

Feb. 26, 2007

Pharmacyclics receives refusal to file letter for Xcytrin

Feb. 23, 2007

Hybrigenics focuses research on USP inhibitors for cancer

Feb. 23, 2007

GPC Biotech launches satraplatin expanded access program

Feb. 23, 2007

Identification of active sites of Polo-like kinases useful for developing new cancer therapies

Feb. 23, 2007

Recent patents cover new therapeutic agents for cancer

Feb. 23, 2007

Vascular disruption agent BNC-105 begins safety studies in animals

Feb. 22, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...